CAR T-Cell Therapies Target BCMA and Alternative Antigens in Multiple Myeloma
New CAR T-cell approaches targeting BCMA and CD19 simultaneously show encouraging early results, while researchers develop control strategies for CAR-T therapies including antibody-drug conjugates.